XNAS: RLMD
Relmada Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently...
Read More
3.83
0.02
(0.52%)
1.3M
XNAS Volume
XNAS 25 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Relmada Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..